https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/biocon-biologics-gets-u-s-fda-approval-for-biosimilar-aflibercept-yesafili-enters-us-ophthalmology-market/110294676
Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US...
Biocon Biologics: After the approval, the company entered the ophthalmology therapeutic area in the United States. Earlier the company also received approvals...